Early stage investors in Cambridge, United Kingdom
Updated 16 Nov 2026
Venture funds
4 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Amadeus Capital Partners Amadeus Capital Partners invests across seed to later stages in the technology sector, with recent investments including Nuclera and Nu Quantum. Cambridge, United Kingdom |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 3 |
| 2 | University of Cambridge Enterprise Cambridge, United Kingdom |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 37% | 3 |
| 3 | Cambridge Innovation Capital Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica. Cambridge, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 36% | 2 |
| 4 | Martlet Capital Martlet Capital provides early-stage patient capital to deep tech and life science startups, including Dogtooth, Infinitopes and Nu Quantum. Cambridge, United Kingdom |
Hardware, Biotech | Seed, Early stage venture | 14% | 2 |
Table 1. Early stage investors in Cambridge, United Kingdom: venture capital and micro VC funds ranked by companies whose Series A and B round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Amadeus Capital Partners | Venture capital firm | Cambridge, United Kingdom | •••@amadeuscapital.com | +44 33••• |
| SyndicateRoom | Micro VC fund | Cambridge, United Kingdom | •••@syndicateroom.com | 01223 ••• |
| University of Cambridge Enterprise | University program | Cambridge, United Kingdom | •••@enterprise.cam.ac.uk | +44 (0••• |
| Cambridge Innovation Capital | Venture capital firm | Cambridge, United Kingdom | •••@cic.vc | +44 (0••• |
| Martlet Capital | Venture capital firm | Cambridge, United Kingdom | •••@martletcap.com | 01223 ••• |
| Cambridge Capital Group | Angel group | Cambridge, United Kingdom | •••@cambridgecapital.com | +44 (0••• |
| Fund Twenty8 | Micro VC fund | Cambridge, United Kingdom | •••@syndicateroom.com | +44 12••• |
| Deeptech Labs | Startup accelerator | Cambridge, United Kingdom | •••@dtl.vc |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 17 of the 23 early stage investors in Cambridge, United Kingdom have a published email address, 15 a phone number and 18 a website.
- Amadeus Capital Partners has the most recorded investments, 293, 86 of them as lead investor.
- 6 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Amadeus Capital Partners is an investor in 5 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 107 portfolio companies (77%).
- Seed is the most common investment stage, recorded for 16 of them (70%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Early stage investors in Cambridge, United Kingdom
18 of 23, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Amadeus Capital Partners | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Hardware | iPronics, Tenzo, Refute | 5 | 293 | 86 | 64 | •••@amadeuscapital.com | +44 33••• | In the CSV |
| 2 | SyndicateRoom | Micro VC fund, Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Fintech | Noggin HQ, Incard | 2 | 135 | 12 | 11 | •••@syndicateroom.com | 01223 ••• | In the CSV |
| 3 | University of Cambridge Enterprise | University program, Venture capital firm | Cambridge, United Kingdom | Health care, Artificial intelligence | T-Therapeutics, Gigaton, Seprify | 3 | 104 | 38 | 7 | •••@enterprise.cam.ac.uk | +44 (0••• | In the CSV |
| 4 | Cambridge Innovation Capital | Venture capital firm | Cambridge, United Kingdom | Hardware, Artificial intelligence | T-Therapeutics, Microbiotica, Salience Labs | 3 | 97 | 35 | 12 | •••@cic.vc | +44 (0••• | In the CSV |
| 5 | Martlet Capital | Venture capital firm | Cambridge, United Kingdom | Hardware, Biotech | Dogtooth, Infinitopes, Nu Quantum | 3 | 51 | 7 | 5 | •••@martletcap.com | 01223 ••• | In the CSV |
| 6 | Cambridge Capital Group | Angel group | Cambridge, United Kingdom | Fintech, Hardware | Arachnys, Augmentra, 10to8 | 45 | 4 | 12 | •••@cambridgecapital.com | +44 (0••• | In the CSV | |
| 7 | Fund Twenty8 | Micro VC fund | Cambridge, United Kingdom | Biotech, Health care | Metrion Biosciences, 2mee, inflo.Ai | 35 | 1 | 1 | •••@syndicateroom.com | +44 12••• | In the CSV | |
| 8 | Meltwind Advisory | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Biotech | CoSyne Therapeutics | 30 | 4 | 0 | 01223 ••• | In the CSV | ||
| 9 | Deeptech Labs | Startup accelerator | Cambridge, United Kingdom | Artificial intelligence, Hardware | Salience Labs, Xapien | 2 | 27 | 2 | 1 | •••@dtl.vc | In the CSV | |
| 10 | Cambridge Future Tech | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Hardware | Literal Labs, Neuro XR, Mission Decisions | 15 | 11 | 0 | •••@camfuturetech.com | In the CSV | ||
| 11 | Invoke Capital | Private equity firm, Venture capital firm | Cambridge, United Kingdom | 9 | 6 | 3 | •••@invokecapital.com | +44 (0••• | In the CSV | |||
| 12 | Acacia Capital Partners | Venture capital firm | Cambridge, United Kingdom | Hardware | Skinkers | 9 | 2 | 3 | •••@acaciacp.com | +44-(0••• | In the CSV | |
| 13 | ETCapital | Venture capital firm | Cambridge, United Kingdom | Hardware | Cyan Technology Ltd | 7 | 1 | 1 | •••@etcapital.com | +44122••• | In the CSV | |
| 14 | NW Brown Ventures | Venture capital firm | Cambridge, United Kingdom | Software | Spikes Cavell & Co, Short Fuze | 5 | 0 | 2 | •••@nwbrown.co.uk | +44 (0••• | In the CSV | |
| 15 | CMS Ventures | Venture capital firm | Cambridge, United Kingdom | 4 | 1 | 0 | •••@cmsventures.com | In the CSV | ||||
| 16 | CREATE Partners | Venture capital firm | Cambridge, United Kingdom | Software | Short Fuze | 4 | 1 | 1 | •••@createpartners.com | 44 (0)••• | ||
| 17 | Brightstar Partners | Venture capital firm | Cambridge, United Kingdom | 1 | 0 | 0 | •••@brightstar-partners.com | In the CSV | ||||
| 18 | Downing Enterprise | Startup accelerator, Entrepreneurship program | Cambridge, United Kingdom | 1 | 0 | 0 | •••@downingenterprise.co.uk | 01223 ••• | In the CSV |
Table 2. Early stage investors in Cambridge, United Kingdom: the first 18 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Amadeus Capital Partners | Cambridge, United Kingdom | 5 | 36 | iPronics, Tenzo, Refute |
| 2 | Cambridge Innovation Capital | Cambridge, United Kingdom | 3 | 11 | T-Therapeutics, Microbiotica, Salience Labs |
| 3 | University of Cambridge Enterprise | Cambridge, United Kingdom | 3 | 10 | T-Therapeutics, Gigaton, Seprify |
| 4 | Martlet Capital | Cambridge, United Kingdom | 3 | 8 | Dogtooth, Infinitopes, Nu Quantum |
| 5 | Deeptech Labs | Cambridge, United Kingdom | 2 | 6 | Salience Labs, Xapien |
| 6 | SyndicateRoom | Cambridge, United Kingdom | 2 | 27 | Noggin HQ, Incard |
Table 3. Early stage investors in Cambridge, United Kingdom: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | Cambridge Innovation Capital, University of Cambridge Enterprise | 51 to 100 | 2022 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge, United Kingdom | Series C | $47.9M | 2026-10-16 | $130.7M | Cambridge Innovation Capital | 11 to 50 | 2016 |
| Salience Labs | Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning. | Artificial intelligence | Oxford, United Kingdom | Series B | $125.0M | 2026-10-14 | $166.5M | Cambridge Innovation Capital, Deeptech Labs | 51 to 100 | 2021 |
| Xapien | Xapien provides AI-powered due diligence and risk intelligence on people, organizations, and business relationships. | Artificial intelligence | London, United Kingdom | Series B | $55.9M | 2026-09-10 | $73.8M | Deeptech Labs | 51 to 100 | 2018 |
| iPronics | iPronics develops programmable optical networking systems for AI data centers and high-performance computing. | Artificial intelligence | Valencia, Spain | Series B | $125.0M | 2026-09-02 | $164.2M | Amadeus Capital Partners | 101 to 250 | 2019 |
| Noggin HQ | Noggin HQ provides credit reference services to assess and report on individuals' creditworthiness. | Fintech | Newcastle Upon Tyne, United Kingdom | Seed | $3.1M | 2026-08-18 | $4.1M | SyndicateRoom | 1 to 10 | 2021 |
| Dogtooth | Dogtooth sells intelligent robots that pick soft fruit. | Hardware | Royston, United Kingdom | Series B | $18.7M | 2026-07-08 | $34.5M | Martlet Capital | 11 to 50 | 2014 |
| Gigaton | Gigaton develops artificial intelligence to help energy-intensive industries reduce their carbon emissions. | Artificial intelligence | London, United Kingdom | Series A | $26.0M | 2026-06-02 | $32.5M | University of Cambridge Enterprise | 11 to 50 | 2020 |
| Tenzo | Tenzo provides a single place to unify a company's tech stack and recommend ways to meet targets. | Software | London, United Kingdom | Series A | $5.0M | 2026-03-31 | $12.7M | Amadeus Capital Partners | 1 to 10 | 2016 |
| Refute | Refute builds software that detects, analyzes, and combats digital misinformation across online platforms. | Artificial intelligence | London, United Kingdom | Seed | $6.8M | 2026-02-03 | $9.7M | Amadeus Capital Partners | 1 to 10 | 2024 |
Table 4. Early stage investors in Cambridge, United Kingdom: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 82 | 77% |
| Artificial intelligence | 33 | 31% |
| Hardware | 27 | 25% |
| Health care | 17 | 16% |
| Fintech | 16 | 15% |
| Biotech | 12 | 11% |
| Commerce | 10 | 9% |
| Cybersecurity | 9 | 8% |
Table 5. Early stage investors in Cambridge, United Kingdom: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 23 | 100% |
| Seed investors | 16 | 70% |
| Late stage investors | 4 | 17% |
| Private equity investors | 2 | 9% |
| Venture investors | 2 | 9% |
Table 6. Early stage investors in Cambridge, United Kingdom by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 2 | 10% |
| 2010s | 8 | 40% |
| 2000s | 6 | 30% |
| 1990s | 2 | 10% |
| 1980s | 1 | 5% |
| 1970s | 1 | 5% |
Table 7. Early stage investors in Cambridge, United Kingdom by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include early stage investors and its headquarters is in Cambridge, United Kingdom. On 16 November 2026 that is 23 investors.
- 17 rows carry an email address and 15 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 18 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 23 rows: 5 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many early stage investors in Cambridge, United Kingdom are on the list?
- 23, in the file dated 16 November 2026. 6 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 17 of the 23 carry an email address in the download and 15 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 23 rows, 17 firm email addresses and 15 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 16 of the 17 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.